TregCelz

TregCelz appears to be an investigational cell-therapy program name associated with Creative Medical Technology and related to ex vivo manipulation of immune cells involving regulatory T cells. Publicly accessible information is too limited to confidently distinguish whether TregCelz is a distinct therapeutic product, an alternate label for the company's broader ImmCelz platform, or an internal/programmatic name rather than a separately defined drug candidate. Based on the available company materials, the underlying concept seems to involve collection of patient white blood cells followed by laboratory reprogramming or stimulation intended to enhance immunomodulatory activity, potentially for autoimmune or inflammatory diseases, but the exact composition, manufacturing process, indication set, and validated mechanism for a specifically named TregCelz product are not clearly established.

Other names

TregCelz